<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04350112</url>
  </required_header>
  <id_info>
    <org_study_id>StOIC-1 Project</org_study_id>
    <nct_id>NCT04350112</nct_id>
  </id_info>
  <brief_title>Study of Opioid-Induced Constipation 1 Project</brief_title>
  <acronym>StOIC-1</acronym>
  <official_title>An Observational Study of Diagnostic Criteria, Clinical Features and Management of Opioid-induced Constipation (OIC) in Patients With Cancer Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Surrey County Hospital NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kyowa Hakko Kirin UK, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Surrey County Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the project is to investigate opioid-induced constipation (OIC) in a real world /
      diverse group of patients with cancer.

      The objectives of the project are to determine: a) prevalence of OIC; b) clinical features /
      impact of OIC; c) management of OIC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      StOIC-1 is an observational study, and will involve a single visit (see below for schedule).

      The following data will be collected: a) demographic data - age, gender, ethnicity; b) cancer
      diagnosis; c) opioid medications - drug, formulation, dose; d) laxative medications - drug,
      formulation, dose; e) other medications; f) Eastern Co-operative Oncology Group performance
      status

      The participants will be asked the following questions:

        1. Simple question - &quot;Are you constipated?&quot; [Options - yes / no / unsure]

        2. European Association for Palliative Care definition question - &quot;Does the following
           question describe your bowel function: 'the passage of small, hard faeces infrequently
           and with difficulty?' [Options - yes / no / unsure]

        3. Camilleri definition question - &quot;Does the following statement describe your bowel
           function: 'a change since initiating opioid therapy from baseline bowel habits that is
           characterised by any of the following: reduced bowel movement frequency, development or
           worsening of straining to pass bowel movements, a sense of incomplete rectal evacuation,
           harder stool consistency?' [Options - yes / no / unsure

        4. Rome IV diagnostic criteria for OIC

      The participants will also be asked to complete:

        1. Bowel function index (BFI). The BFI is a validated, 3 item, patient-reported tool for
           assessing the treatment of OIC. A BFI score of ≥30 indicates suboptimally treated OIC.

        2. Patient Assessment of Constipation - Quality of Life Questionnaire (PAC-QOL). The
           PAC-QOL is a validated, 28-item, patient-reported tool for assessing the impact of
           constipation over time.

        3. Memorial Symptom Assessment Scale - Short Form (MSAS-SF). The MSAS-SF is a validated, 32
           item, patient-reported tool for assessing physical and psychological symptoms in cancer
           patients.

      The participant will also undergo a palliative care specialist assessment for constipation /
      OIC. The palliative care specialist will be asked to review the patient with regard to their
      bowel function, and then asked the following questions: a) does the patient have
      constipation? [Options - yes / no / unsure]; b) (if appropriate) does the patient have
      opioid-induced constipation? [Options - yes / no / unsure]; c) (if appropriate) does the
      patient have additional causes of constipation? [Options - yes / no / unsure]; d) (if
      appropriate) what additional causes of constipation?I
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 21, 2017</start_date>
  <completion_date type="Actual">August 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of opioid-induced constipation</measure>
    <time_frame>1 week</time_frame>
    <description>Clinician assessment</description>
  </primary_outcome>
  <enrollment type="Actual">1007</enrollment>
  <condition>Opioid-induced Constipation</condition>
  <condition>Cancer</condition>
  <condition>Cancer Pain</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical assessment</intervention_name>
    <description>Clinical assessment (history, examination) is gold standard for diagnosing constipation - gold standard will be compared with simple question about constipation, Rome IV diagnostic criteria for OIC, and common definitions of constipation for constipation / OIC</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        1000 subjects that are either inpatients or outpatients at study sites (hospitals and
        hospices in the United Kingdom)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18yr; diagnosis of cancer; diagnosis of cancer pain; receipt of regular opioids
             for at least one week

        Exclusion Criteria:

          -  Inability to give informed consent; inability to complete questionnaire
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew N Davies, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant Palliative Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Cornwall Hospital</name>
      <address>
        <city>Truro</city>
        <state>Cornwall</state>
        <zip>TR1 3LQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brighton &amp; Sussex University Hospitals</name>
      <address>
        <city>Brighton</city>
        <state>East Sussex</state>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leckhampton Court Hospice</name>
      <address>
        <city>Cheltenham</city>
        <state>Gloucestershire</state>
        <zip>GL53 0QJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospice of St. Francis</name>
      <address>
        <city>Berkhamstead</city>
        <state>Hertfordshire</state>
        <zip>HP43GW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart of Kent Hospice</name>
      <address>
        <city>Maidstone</city>
        <state>Kent</state>
        <zip>ME20 7PU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wisdom Hospice</name>
      <address>
        <city>Rochester</city>
        <state>Kent</state>
        <zip>ME1 2NU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Raphael's Hospice</name>
      <address>
        <city>Cheam</city>
        <state>London</state>
        <zip>SM3 9DX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nottingham University Hospitals</name>
      <address>
        <city>Nottingham</city>
        <state>Nottinghamshire</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Margaret's Hospice</name>
      <address>
        <city>Yeovil</city>
        <state>Somerset</state>
        <zip>BA20 2HU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Giles Hospice</name>
      <address>
        <city>Lichfield</city>
        <state>Staffordshire</state>
        <zip>WS14 9LH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Surrey County Hospital</name>
      <address>
        <city>Guildford</city>
        <state>Surrey</state>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham St. Mary's Hospice</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B29 7DA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Catherine's Hospice</name>
      <address>
        <city>Crawley</city>
        <state>West Sussex</state>
        <zip>RH10 6BH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Gemma's Hospice</name>
      <address>
        <city>Leeds</city>
        <state>Yorkshire</state>
        <zip>LS17 6QD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wheatfields Hospice</name>
      <address>
        <city>Leeds</city>
        <state>Yorkshire</state>
        <zip>LS6 2AE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Hospice</name>
      <address>
        <city>Sheffield</city>
        <state>Yorkshire</state>
        <zip>S11 9NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <results_reference>
    <citation>Camilleri M, Drossman DA, Becker G, Webster LR, Davies AN, Mawe GM. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil. 2014 Oct;26(10):1386-95. doi: 10.1111/nmo.12417. Epub 2014 Aug 28. Review.</citation>
    <PMID>25164154</PMID>
  </results_reference>
  <results_reference>
    <citation>Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW; European Consensus Group on Constipation in Palliative Care. The management of constipation in palliative care: clinical practice recommendations. Palliat Med. 2008 Oct;22(7):796-807. doi: 10.1177/0269216308096908. Review. Erratum in: Palliat Med. 2009 Jun;23(4):376.</citation>
    <PMID>18838491</PMID>
  </results_reference>
  <results_reference>
    <citation>Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016 Feb 18. pii: S0016-5085(16)00222-5. doi: 10.1053/j.gastro.2016.02.031. [Epub ahead of print]</citation>
    <PMID>27144627</PMID>
  </results_reference>
  <results_reference>
    <citation>Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR. Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med. 2015 Dec;16(12):2324-37. doi: 10.1111/pme.12937. Epub 2015 Nov 19. Review.</citation>
    <PMID>26582720</PMID>
  </results_reference>
  <results_reference>
    <citation>Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000 Sep 1;89(5):1162-71.</citation>
    <PMID>10964347</PMID>
  </results_reference>
  <results_reference>
    <citation>Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005 May;40(5):540-51.</citation>
    <PMID>16036506</PMID>
  </results_reference>
  <results_reference>
    <citation>Rentz AM, Yu R, Müller-Lissner S, Leyendecker P. Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ. 2009;12(4):371-83. doi: 10.3111/13696990903430481.</citation>
    <PMID>19912069</PMID>
  </results_reference>
  <results_reference>
    <citation>Ueberall MA, Müller-Lissner S, Buschmann-Kramm C, Bosse B. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients. J Int Med Res. 2011;39(1):41-50.</citation>
    <PMID>21672306</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 13, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2020</study_first_posted>
  <last_update_submitted>April 15, 2020</last_update_submitted>
  <last_update_submitted_qc>April 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Opioid-induced constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Currently, there are no plans to make IPD available to other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

